On November 20, 2024, the Association of Cannabinoid Specialists was joined by Dr. Sandra Carrillo as she presented a symposium on Cannabis and Epilepsy.

Preclinical data supports the use of cannabinoids for gastrointestinal inflammation, but does this translate into patient outcomes?

When considering medical cannabis, patients often have numerous questions for their physicians. These questions typically revolve around safety, efficacy, legal issues, and personal concerns. Here are some of the most common questions patients are likely to ask their physicians about medical cannabis:

With the incidence of colitis on the rise, is cannabis the cure we’ve been waiting for?

While cannabis as medicine is not new, the healthcare provider’s venture into the cannabis industry may be a new journey for many. In state medical marijuana programs doctors are the people who “recommend” cannabis (presently there is no actual prescription for cannabis).

The Association of Cannabinoid Specialists (ACS) is an international non-profit organization of physicians and other health professionals specializing in using cannabis or cannabinoids, as appropriate, for the care and treatment of patients suffering from a range of debilitating conditions such as cancer, Crohn’s disease, AIDS, multiple sclerosis, Parkinson’s disease, epilepsy, autism, and post-traumatic stress disorder, and patients with terminal illnesses.

Over the years, I have had the privilege of caring for a multitude of patients turning to cannabis as a therapeutic option for anxiety, spanning from general anxiety disorder and situational anxiety to its role in managing PTSD and accompanying depression.

The human body is a complex network of interacting systems, each with its own set of responsibilities. Among these intricate systems is the endocannabinoid system (ECS), a fascinating and relatively recent discovery in the field of neuroscience.

In an editorial in JAMA, Dr. Nathaniel Morris, a recent Stanford graduate, laments that even in California where medical cannabis has been available since 1996, no medical education on cannabis was provided to him during medical school or residency.

On January 30, 2024, the Association of Cannabinoid Specialists hosted our quarterly virtual Student Education Series.  ACS was proud to welcome Suraj Tandon, MD, FRCPC, DABIM as its speaker on the topic of Basics of Medical Cannabis.  To watch the full presentation, click here.